More broadly, CDKL5 inhibition is beneficial for cell survival upon ischemia or nephrotoxin-induced kidney injury (Kim et al., 2020b; Kim et al., 2020a), suggesting that the inhibitors we characterized here may prove useful to evaluate the promise of CDKL5 inhibition in other disease models. The gene discussed is CDKL5; the disease is kidney injury.